These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16150099)
1. Guillain-Barré syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Hernández-Boluda JC; Lis MJ; Goterris R; Arbona C; Terol MJ; Tormo M; Solano C Transpl Infect Dis; 2005 Jun; 7(2):93-6. PubMed ID: 16150099 [TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation. Du J; Liu J; Gu J; Zhu P Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570 [TBL] [Abstract][Full Text] [Related]
10. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279 [TBL] [Abstract][Full Text] [Related]
11. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome after bone marrow transplantation. Perry A; Mehta J; Iveson T; Treleaven J; Powles R Bone Marrow Transplant; 1994 Jul; 14(1):165-7. PubMed ID: 7951108 [TBL] [Abstract][Full Text] [Related]
13. Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection. Mori T; Okamoto S; Watanabe R; Yamazaki R; Tsukada Y; Nagayama H; Ishida A; Ikeda Y Bone Marrow Transplant; 2002 Jun; 29(12):1005-6. PubMed ID: 12098071 [No Abstract] [Full Text] [Related]
14. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringdén O Haematologica; 2006 Jan; 91(1):78-83. PubMed ID: 16434374 [TBL] [Abstract][Full Text] [Related]
15. Neurological manifestation of CMV disease after allogeneic haematopoietic stem cells transplantation--a case report. Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):198-200. PubMed ID: 16146077 [TBL] [Abstract][Full Text] [Related]
16. An adolescent with pharyngeal-cervical-brachial variant of Guillain-Barré syndrome after cytomegalovirus infection. Murakami N; Tomita Y; Koga M; Takahashi E; Katada Y; Sakuta R; Nagai T Brain Dev; 2006 May; 28(4):269-71. PubMed ID: 16368212 [TBL] [Abstract][Full Text] [Related]
18. Cerebral toxoplasmosis and Guillain-Barré syndrome after allogeneic peripheral stem cell transplantation. González MI; Caballero D; López C; Alburquerque T; Hernández R; de la Loma A; Cañizo C; Vázquez L; San Miguel JF Transpl Infect Dis; 2000 Sep; 2(3):145-9. PubMed ID: 11429026 [TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide. Ehlert K; Groll AH; Kuehn J; Vormoor J Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677 [TBL] [Abstract][Full Text] [Related]
20. [Steroid-pulse therapy in Guillain-Barré syndrome associated with cytomegalovirus infection: a case report]. Tada M; Onodera O; Kawachi I; Hara K; Sato M; Yoshino H; Asano A; Soma Y; Tsuji S No To Shinkei; 2003 Jul; 55(7):615-21. PubMed ID: 12910997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]